LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Ricks David A2023/03/21SVP and Pres, Lilly Bio-Meds170728-408462023-03-2100000594780000059478129882
-
Hedley Mary Lynne2023/03/20512023-03-200000059478000005947851
-
Hedley Mary Lynne2023/03/19512023-03-190000059478000005947851
-
Hedley Mary Lynne2023/03/18512023-03-180000059478000005947851
-
Hedley Mary Lynne2023/03/17512023-03-170000059478000005947851
-
Hedley Mary Lynne2023/03/16512023-03-160000059478000005947851
-
Ricks David A2023/03/15SVP and Pres, Lilly Bio-Meds170728-408462023-03-1500000594780000059478129882
-
Tapiero Jacques2023/03/14SVP&Pres.-Emerging Markets BU148822023-03-140000059478000005947814882
-
Hedley Mary Lynne2023/03/13512023-03-130000059478000005947851
-
Zakrowski Donald A2023/03/12Chief Accounting Officer46594-272002023-03-120000059478000005947819394
Related News

BlackRock (NYSE:BLK) Stock: A Resilient Investment at $747.91 With Promising Growth Ahead
TradingNEWS Archive
11.05.25

Can NASDAQ:BIDU Surge Above $200? How Will AI and Robotaxi Businesses Impact Baidu’s Future Price?
TradingNEWS Archive
10.05.25

Is NASDAQ: INTC Ready for a Strong Recovery in 2025?
TradingNEWS Archive
10.05.25

Shell’s Bold Move: Can a Potential BP Acquisition Propel NYSE:SHEL to New Heights Amid $60 Brent Prices?
TradingNEWS Archive
09.05.25